Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 229-236

  Asano, Kazuhito ^a   Satoh, Kazue ^a   Hosaka, Mahina ^a   Arakawa, Hidetoshi ^a   Inagaki, Masahiro ^a   Hisamitsu, Tadashi ^a   Maeda, Masako ^a   Kochi, Mutsuyuki ^b   Sakagami, Hiroshi ^c  

^a SHOWA UNIVERSITY   (Japan)

^b Ichijokai Hospital   (Japan)

^c MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

ESR; H2O2; Hepatocellular carcinoma; Radical; Sodium 5,6 benzylidene L ascorbate

Indexed keywords

4 DIMETHYLAMINO 3' METHYLAZOBENZENE; 5,6 BENZYLIDENEASCORBIC ACID; ANTINEOPLASTIC AGENT; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CELL DEGENERATION; CELL VACUOLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ELECTRON SPIN RESONANCE; EOSINOPHIL; INTRAVENOUS DRUG ADMINISTRATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ASCORBIC ACID; BENZYLIDENE COMPOUNDS; CHEMILUMINESCENT MEASUREMENTS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICALS; HYDROGEN PEROXIDE; MALE; NEOPLASMS, EXPERIMENTAL; RATS;

EID: 0032955772     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kochi M, Ueda S and Hagiwara T: Antitumor activity of sodium benzylideneascorbate. In: F Bresciani, RJB King, MF Lippman, JP Raynaud (eds), Progress in Cancer Research and Therapy. vol 35 pp 338-343. Hormones and Cancer 3, Raven Press, Ltd. New York, 1988.
2. Sakagami H, Asano K, Fukuchi K, Gomi K, Ota H, Kazama K, Tanuma, S and Kochi M: Induction of tumor degeneration by sodium benzylideneascorbate. Anticancer Res 11: 1533-1538, 1991.
3. Sakagami H, Sakagami T, Takeda M, Iwaki K and Takeda K: Determination of sodium 5,6-benzylidene-L-ascorbate and related compounds by high-performance liquid chromatography. J Chromatogr A 653: 37-43, 1993.
4. Sakagami H, Sakagami T, Yamamura M, Takahashi H, Shibuya I and Takeda M: Stability of sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 15: 1269-1274, 1995.
5. Kuribayashi N, Sakagami H, Sakagami T, Niimi E, Shiokawa D, Ikekita M, Takeda M and Tanuma S: Induction of DNA fragmentation in human myclogenous leukemic cell lines by sodium 5,6-benzylidene-L-ascorbate and its related compounds. Anticancer Res 14: 969-976, 1994.
6. Sakagami H, Kuribayashi N, Iida M, Hagiwara T, Takahashi H, Yoshida H, Shiota F, Ohata H, Momose K and Takeda M: The requirement for and mobilization of calcium during induction by sodium ascorbate and by hydrogen peroxide of cell death. Life Sciences 58: 1131-1138, 1996.
7. Tanuma S, Shiokawa D, Tanimoto Y, Ikekita M, Sakagami H, Takeda M, Fukuda S and Kochi M: Benzylideneascorbate induces apoptosis in L929 tumor cells. Biochem Biophys Res Commun 194: 29-35, 1993.
8. Sakagami H, Satoh K, Ohata H, Takahashi H, Yoshida H, Iida M, Kuribayashi N, Sakagami T, Momose K, and Takeda M: Relationship between ascorbyl radical intensity and apoptosis-inducing activity. Anticancer Res 16: 2635-2644, 1996.
9. Sakagami H, and Satoh K: Prooxidant action of two antioxidants: ascorbic acid and gallic acid. Anticancer Res 17: 221-224, 1997.
10. Sakagami H, Satoh K, Kadofuku T, and Takeda M: Methionine oxidation and apoptosis induction by ascorhate, gallate and hydrogen peroxide. Anticancer Res 17: 2565-2570, 1997.
11. Tajima M, Toguchi M, Kanda Y, Kunii S, Hosaka M, Arakawa H, Maeda M, Satoh K, Asano K, Kochi M, and Sakagami H: Role of hydrogen peroxide for cell death induction by sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 18: 1697-1702, 1998.
12. Ota H, Kazama K, Yoshida H, Takeda M, and Sakagami H: Rat hepatocellular carcinogenesis and proliferating cell nuclear antigen expression induced by 3'-methyl-4-dimethylaminoazobenzene. In Vivo 8: 289-294, 1994.
13. Sakagami H, Satoh K, Fukuchi K, Gomi K, and Takeda M: Effect of an iron-chelator on ascorbate-induced cytotoxicity. Free Radic Biol Med 23: 260-270, 1997.
14. Satoh K, Ao Y, Asano K, and Sakagami H: Rapid determination of ascorbate by ESR spectroscopy. Anticancer Res 17: 3479-3483, 1997.
15. Satoh K, Ida Y, Asano K, Hisamitsu T, Inagaki M, Sho S, Kochi M, Tanaka T, and Sakagami H: Effect of physiological fluids on radical intensity of sodium ascorbate and sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 17: 4457-4462, 1997.
16. Kawase M, Motohashi N, Kurihara T, Inagaki M, Satoh K, and Sakagami H: Relationship between radical intensity and cytotoxic activity of dopamine-related compounds. Anticancer Res 18: 1069-1074, 1998.
17. Arakawa H, Maeda M, and Tsuji A: Chemiluminescence enzyme immunoassay for thyroxin with use of glucose oxidase and a bis(2,4,6-trichlorophenyl)oxalate-fluorescent dye system. Clinical Chem 31: 109-113, 1985.
18. Sakagami H, Hosaka M, Arakawa H, Maeda M, Satoh K, Ida Y, Asano K, Hisamitsu T, Takimoto M, Ota H, Inagaki M, Sasuga K, Sho S, Tanaka T, Utsumi N, Oi T, and Kochi M: Role of hydrogen peroxide in antitumor activity induction by sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 18: 2519-1514, 1998.
19. Cammack J, Ghasemzadeh B, and Adams RN: Electrochemical monitoring of brain ascorbic acid changes associated with hypoxia, spreading depression and seizure activity. Neurochem Res 17: 23-27, 1992.
20. Yanagisawa-Shiota F, Sakagami H, Kuribayashi N, Iida M, Sakagami T, and Takeda M: Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anticancer Res 15: 259-266, 1995.
21. Basu TK, Donaldson D, Jenner M, Williams DC, and Sakula A: Plasma vitamin A in patients with bronchial carcinoma. Br J Cancer 33: 119-121, 1976.
22. Bozzi A, Mavelli I, Mondovi B, Strom R, and Rotilio G: Differential sensitivity of tumor cells to externally generated hydrogen peroxide. Role of glutathione and related enzymes. Cancer Biochem Biophys 3: 135-141, 1979.
23. Fujinaga S, Sakagami H, Kurihayashi N, Takahashi H, Amano Y, Sakagami T, and Takeda M: Possible role of hydrogen peroxide in apoptosis induction by ascorbic acid in human myelogenous leukemic cell lines. Showa Univ J Med Sci 6: 135-144, 1994.
24. Mashiba H, and Matsunaga K: Device for intracellular increase of oxygen free radicals and inhibition of Meth A tumour cell proliferation: In vitro and in vivo studies. Int J Tissue Reac X: 273-280, 1988.
25. Orr CWM: The inhibition of catalase (hydrogen-peroxide: hydrogen peroxide oxireductase, EC 1.11.1.6) by ascorbate. In: DB McCormick, and LD Wright (eds.), Mehods in Enzymology vol XVIII, pp 59-65, Academic Press, New York, 1970.
26. Sestili P, Brandi G, Brambilla L, Cattabeni F, and Cantoni O: Hydrogen peroxide mediates the killing of U-937 tumor cells elicited by pharmacologically attainable concentrations of ascorbic acid: cell death prevention by extracellular catalase or catalase from cocultured erythrocytes or fibroblasts. J Pharmacol Exp Ther 277: 1719-1725, 1996.
27. Sakagami H, and Satoh K: The interaction between two antioxidants. sodium ascorbate and gallic acid: radical intensity and apoptosis induction. Anticancer Res 16: 1231-1234, 1996.
28. Sakagami H, Satoh K, Hatano T, Yoshida T, and Okuda T: Possible role of radical intensity and oxidation potential for gallic acid-induced apoptosis. Anticancer Res 17: 377-380, 1997.
29. Satoh K, Sakagami H, Kurihara T, and Motohashi N: Radical intensity and differentiation-inducing activity of benzo[a]phenothiazines and phenothiazines. Anticancer Res 17: 2465-2470, 1997.
30. Sakagami H, Satoh K, Aiuchi T, Nakaya K, and Takeda M: Stimulation of ascorbate-induced hypoxia by lignin. Anticancer Res 17: 1213-1216, 1997.
31. An WG, Kenekal M, Simon MC, Maltepe E, Blagosklonny MV, and Neckers LM: Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 392: 405-408, 1998.
32. Luo Y, Umegaki H, Wang X, Abe R, and Roth GS: Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 273: 3756-3764, 1998.